Post-approval studies (Phase 4)Study completedNCT00607958
What this trial is testing
Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 11